DG(16:0/18:1(9Z)/0:0) (BioDeep_00000009627)
Secondary id: BioDeep_00000631492
human metabolite Endogenous blood metabolite natural product
代谢物信息卡片
化学式: C37H70O5 (594.5223)
中文名称: 1-棕榈酰-2-油酸甘油酯
谱图信息:
最多检出来源 Homo sapiens(lipidomics) 97.45%
Last reviewed on 2024-09-24.
Cite this Page
DG(16:0/18:1(9Z)/0:0). BioDeep Database v3. PANOMIX ltd, a top metabolomics service provider from China.
https://query.biodeep.cn/s/dg(16:0_18:1(9z)_0:0) (retrieved
2024-12-23) (BioDeep RN: BioDeep_00000009627). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
分子结构信息
SMILES: CCCCCCCC/C=C\CCCCCCCC(=O)O[C@@H](CO)COC(=O)CCCCCCCCCCCCCCC
InChI: InChI=1S/C37H70O5/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-37(40)42-35(33-38)34-41-36(39)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h17-18,35,38H,3-16,19-34H2,1-2H3/t35-/m0/s1
描述信息
DG(16:0/18:1(9Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(16:0/18:1(9Z)/0:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of oleic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the oleic acid moiety is derived from vegetable oils, especially olive and canola oil. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. Synthesis of diacylglycerol begins with glycerol-3-phosphate, which is derived primarily from dihydroxyacetone phosphate, a product of glycolysis (usually in the cytoplasm of liver or adipose tissue cells). Glycerol-3-phosphate is first acylated with acyl-coenzyme A (acyl-CoA) to form lysophosphatidic acid, which is then acylated with another molecule of acyl-CoA to yield phosphatidic acid. Phosphatidic acid is then de-phosphorylated to form diacylglycerol.Diacylglycerols are precursors to triacylglycerols (triglyceride), which are formed by the addition of a third fatty acid to the diacylglycerol under the catalysis of diglyceride acyltransferase. Since diacylglycerols are synthesized via phosphatidic acid, they will usually contain a saturated fatty acid at the C-1 position on the glycerol moiety and an unsaturated fatty acid at the C-2 position.
DG(16:0/18:1(9Z)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(16:0/18:1(9Z)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.
同义名列表
31 个代谢物同义名
(2S)-1-(hexadecanoyloxy)-3-hydroxypropan-2-yl (9Z)-octadec-9-enoate; 1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycerol; 1-Palmitoyl-2-oleoyl-sn-glycerol, (S)-isomer; 1-(1-14C)Palmitoyl-2-oleoyl-sn-glycerol; 1-Palmitoyl-2-(1-14C)oleoyl-sn-glycerol; Diacylglycerol(16:0/18:1(9Z)/0:0); 1-Palmitoyl-2-oleoyl-rac-glycerol; 1-Palmitoyl-2-oleoyl-sn-glycerol; 1-Palmitoyl-2-oleoylglycerol; Diacylglycerol(16:0/18:1n9); Diacylglycerol(16:0/18:1W9); Diacylglycerol(16:0/18:1); DG (16:0/18:1(N-9)/0:0); DAG(16:0/18:1(9Z)/0:0); DG(16:0/18:1(9Z)/0:0); Diacylglycerol(34:1); DG(16:0/18:1/0:0); DAG(16:0/18:1N9); DAG(16:0/18:1W9); DG(16:0/18:1W9); DG(16:0/18:1N9); Diacylglycerol; DAG(16:0/18:1); DG(16:0/18:1); DG(16:0_18:1); Diglyceride; 1-(14C)POG; 2-(14C)POG; DAG(34:1); DG(34:1); DG 34:1
数据库引用编号
16 个数据库交叉引用编号
- ChEBI: CHEBI:75466
- KEGG: C13861
- PubChem: 5282283
- PubChem: 151082
- HMDB: HMDB0007102
- Metlin: METLIN4260
- LipidMAPS: LMGL02010006
- MetaCyc: DIACYLGLYCEROL
- foodb: FDB024296
- chemspider: 4445454
- CAS: 29541-66-0
- PMhub: MS000023429
- PubChem: 854106
- 3DMET: B04605
- NIKKAJI: J67.984D
- LOTUS: LTS0170978
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
145 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(145)
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(5Z,8Z,11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)):
Hydrogen Ion + L-Serine ⟶ Carbon dioxide + Ethanolamine
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/16:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/22:1(13Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:1(13Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:4(7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:4(8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/22:0):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:0):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:0):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)):
Adenosine triphosphate + Choline ⟶ Adenosine diphosphate + Phosphorylcholine
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)):
Adenosine triphosphate + Choline ⟶ Adenosine diphosphate + Phosphorylcholine
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)):
Adenosine triphosphate + Choline ⟶ Adenosine diphosphate + Phosphorylcholine
- Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z)):
Adenosine triphosphate + Choline ⟶ Adenosine diphosphate + Phosphorylcholine
- Array:
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- Array:
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/14:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/16:0):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:0):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:1(9Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:1(11Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/18:3(6Z,9Z,12Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:1(11Z)):
TG(16:0/18:1(9Z)/20:1(11Z))[iso6] + Water ⟶ 11Z-Eicosenoic acid + DG(16:0/18:1(9Z)/0:0) + Hydrogen Ion
- Triacylglycerol Degradation TG(16:0/18:1(9Z)/20:1(13Z)):
Adenosine triphosphate + Glycerol ⟶ Adenosine diphosphate + Glycerol 3-phosphate + Hydrogen Ion
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(11Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(11Z)):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/16:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:4(6Z,9Z,12Z,15Z)):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Joubert Syndrome:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Joubert Syndrome:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Phosphatidylinositol Phosphate Metabolism:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- Joubert Syndrome:
CDP-DG(16:0/18:1(9Z)) + myo-Inositol ⟶ Cytidine monophosphate + PI(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:0):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:2(13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:2(13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:2(13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:2(13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/24:1(15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)):
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)):
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)):
CDP-DG(16:0/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + PS(16:0/18:1(9Z))
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)):
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- Phosphatidylethanolamine Biosynthesis PE(16:0/18:1(9Z)):
L-Serine + PC(16:0/18:1(9Z)) ⟶ Choline + PS(16:0/18:1(9Z))
- phospholipid biosynthesis CL(16:0/18:1(9Z)/16:0/18:1(9Z)):
CDP-DG(19:1(9Z)/18:1(9Z)) + L-Serine ⟶ Cytidine monophosphate + Hydrogen Ion + PS(19:iso/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:2(11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:2(11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:2(11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:3(9Z,12Z,15Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:2(11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/20:3(8Z,11Z,14Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/22:5(4Z,7Z,10Z,13Z,16Z)):
LPA(16:0/0:0) + Oleoyl-CoA ⟶ Coenzyme A + PA(16:0/18:1(9Z))
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:1(9Z)):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
- De Novo Triacylglycerol Biosynthesis TG(16:0/18:1(9Z)/18:2(9Z,12Z)):
PA(16:0/18:1(9Z)) + Water ⟶ DG(16:0/18:1(9Z)/0:0) + Phosphate
PharmGKB(0)
9 个相关的物种来源信息
- 7458 - Apidae: LTS0170978
- 7459 - Apis: LTS0170978
- 7461 - Apis cerana: 10.1371/JOURNAL.PONE.0175573
- 7461 - Apis cerana: LTS0170978
- 6656 - Arthropoda: LTS0170978
- 2759 - Eukaryota: LTS0170978
- 9606 - Homo sapiens: -
- 50557 - Insecta: LTS0170978
- 33208 - Metazoa: LTS0170978
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
文献列表
- Yasuyuki Hashidoko, Hiroaki Nishizuka, Manato Tanaka, Kanako Murata, Yuta Murai, Makoto Hashimoto. Isolation and characterization of 1-palmitoyl-2-linoleoyl-sn-glycerol as a hormogonium-inducing factor (HIF) from the coralloid roots of Cycas revoluta (Cycadaceae).
Scientific reports.
2019 03; 9(1):4751. doi:
10.1038/s41598-019-39647-8
. [PMID: 30894551] - Dorottya Nagy-Szakal, Dinesh K Barupal, Bohyun Lee, Xiaoyu Che, Brent L Williams, Ellie J R Kahn, Joy E Ukaigwe, Lucinda Bateman, Nancy G Klimas, Anthony L Komaroff, Susan Levine, Jose G Montoya, Daniel L Peterson, Bruce Levin, Mady Hornig, Oliver Fiehn, W Ian Lipkin. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Scientific reports.
2018 07; 8(1):10056. doi:
10.1038/s41598-018-28477-9
. [PMID: 29968805] - Takaoki Koyanagi, Geoffray Leriche, Alvin Yep, David Onofrei, Gregory P Holland, Michael Mayer, Jerry Yang. Effect of Headgroups on Small-Ion Permeability across Archaea-Inspired Tetraether Lipid Membranes.
Chemistry (Weinheim an der Bergstrasse, Germany).
2016 06; 22(24):8074-7. doi:
10.1002/chem.201601326
. [PMID: 27142341] - Celia Carrillo, Aziz Hichami, Pierre Andreoletti, Mustapha Cherkaoui-Malki, María del Mar Cavia, Souleymane Abdoul-Azize, Sara R Alonso-Torre, Naim Akhtar Khan. Diacylglycerol-containing oleic acid induces increases in [Ca(2+)](i) via TRPC3/6 channels in human T-cells.
Biochimica et biophysica acta.
2012 Apr; 1821(4):618-26. doi:
10.1016/j.bbalip.2012.01.008
. [PMID: 22306362] - Masao Shimizu, Junya Moriwaki, Daisuke Shiiba, Hidenori Nohara, Naoto Kudo, Yoshihisa Katsuragi. Elimination of glycidyl palmitate in diolein by treatment with activated bleaching earth.
Journal of oleo science.
2012; 61(1):23-8. doi:
10.5650/jos.61.23
. [PMID: 22188803] - Hugh I Kim, Hyungjun Kim, Young Shik Shin, Luther W Beegle, Seung Soon Jang, Evan L Neidholdt, William A Goddard, James R Heath, Isik Kanik, J L Beauchamp. Interfacial reactions of ozone with surfactant protein B in a model lung surfactant system.
Journal of the American Chemical Society.
2010 Feb; 132(7):2254-63. doi:
10.1021/ja908477w
. [PMID: 20121208] - Sarah A Scott, Paige E Selvy, Jason R Buck, Hyekyung P Cho, Tracy L Criswell, Ashley L Thomas, Michelle D Armstrong, Carlos L Arteaga, Craig W Lindsley, H Alex Brown. Design of isoform-selective phospholipase D inhibitors that modulate cancer cell invasiveness.
Nature chemical biology.
2009 Feb; 5(2):108-17. doi:
10.1038/nchembio.140
. [PMID: 19136975] - A M Jiménez-Monreal, F J Aranda, V Micol, P Sánchez-Piñera, A de Godos, J C Gómez-Fernández. Influence of the physical state of the membrane on the enzymatic activity and energy of activation of protein kinase C alpha.
Biochemistry.
1999 Jun; 38(24):7747-54. doi:
10.1021/bi983062z
. [PMID: 10387014] - A K Hinderliter, A R Dibble, R L Biltonen, J J Sando. Activation of protein kinase C by coexisting diacylglycerol-enriched and diacylglycerol-poor lipid domains.
Biochemistry.
1997 May; 36(20):6141-8. doi:
10.1021/bi962715d
. [PMID: 9166785]